Abstract
Oxidized low density lipoprotein (oxLDL) has been identified as a potentially important atherogenic factor. Atherosclerosis is characterized by the accumulation of lipid and calcium in the vascular wall. OxLDL plays a significant role in altering calcium homeostasis within different cell types. In our previous study, chronic treatment of vascular smooth muscle cells (VSMC) with oxLDL depressed Ca2+ i homeostasis and altered two Ca2+ release mechanisms in these cells (IP3 and ryanodine sensitive channels). The purpose of the present study was to further define the effects of chronic treatment with oxLDL on the smooth muscle sarcoplasmic reticulum (SR) Ca2+ pump. One of the primary Ca2+ uptake mechanisms in VSMC is through the SERCA2 ATPase calcium pump in the sarcoplasmic reticulum. VSMC were chronically treated with 0.005-0.1 mg/ml oxLDL for up to 6 days in culture. Cells treated with oxLDL showed a significant increase in the total SERCA2 ATPase content. These changes were observed on both Western blot and immunocytochemical analysis. This increase in SERCA2 ATPase is in striking contrast to a significant decrease in the density of IP3 and ryanodine receptors in VSMC as the result of chronic treatment with oxLDL. This response may suggest a specific adaptive mechanism that the pump undergoes to attempt to maintain Ca2+ homeostasis in VSMC chronically exposed to atherogenic oxLDL.
Similar content being viewed by others
References
Ross R: Rous-Whipple Award Lecture. Atherosclerosis: A defense mechanism gone awry. Am J Pathol 143: 987–1002, 1993
Munro JM, Cotran RS: The pathogenesis of atherosclerosis: Atherogenesis and inflammation. Lab Invest 58: 249–261, 1988
Fleckenstein A, Frey M, Thimm F, Fleckenstein GG: Excessive mural calcium overload–a predominant causal factor in the development of stenosing coronary plaques in humans. Cardiovasc Drugs Ther 5(suppl 4): 1005–1013, 1990
Fleckenstein GG, Fleckenstein A: Calcium–a neglected key factor in arteriosclerosis. The pathogenic role of arterial calcium overload and its prevention by calcium antagonists. Ann Med 23: 589–599, 1991
Massaeli H, Pierce GN: Involvement of lipoproteins, free radicals, and calcium in cardiovascular disease processes. Cardiovasc Res 29: 597–603, 1995
Massaeli H, Austria JA, Pierce G N: Chronic exposure of smooth muscle cells to minimally oxidized low density lipoprotein results in depressed IP3 receptor density and Ca2+ transients. Circ Res 85: 515–523, 1999
Massaeli H, Austria JA, Pierce GN: Lesions in smooth muscle sarcoplasmic reticulum during atherosclerosis: The involvement of oxidized low density lipoprotein. Arterioscl Thromb Vasc Biol 20: 328–334, 2000
Liu K, Massaeli H, Pierce GN: The action of oxidized low density lipoprotein on calcium transients in isolated rabbit cardiomyocytes. J Biol Chem 268: 4145–4151, 1993
Kutryk MJ, Maddaford TG, Ramjiawan B, Pierce GN: Oxidation of membrane cholesterol alters active and passive transsarcolemmal calcium movement. Circ Res 68: 18–26, 1991
Liu KZ, Maddaford TG, Ramjiawan B, Kutryk MJ, Pierce GN: Effects of cholesterol oxidase on cultured vascular smooth muscle cells. Mol Cell Biochem 108: 39–48, 1991
Lowry OH, Rosebrough NJ, Farr AL, Randall AJ: Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265–275, 1951
Liu KZ, Ramjiawan B, Kutryk MJ, Pierce GN: Effects of oxidative modification of cholesterol in isolated low density lipoproteins on cultured smooth muscle cells. Mol Cell Biochem 108: 49–56, 1991
Liu K, Pierce GN: The effects of low density lipoprotein on calcium transients in isolated rabbit cardiomyocytes. J Biol Chem 268: 3767–3775, 1993
Omodeo-Sale F, Marchesini S, Fishman PH, Berra B: A sensitive enzymatic assay for determination of cholesterol in lipid extracts. Anal Biochem 142: 347–350, 1984
Milne DB, Botnen J: Retinol, alpha-tocopherol, lycopene, and alpha-and beta-carotene simultaneously determined in plasma by isocratic liquid chromatography. Clin Chem 32: 874–876, 1986
Grünwald J, Haudenschild CC: Intimal injury in vivo activates vascular smooth muscle cell migration and explant outgrowth in vitro. Arteriosclerosis 4: 183–188, 1984
Libby P, O'Brien KV: Culture of quiescent arterial smooth muscle cells in a defined serum-free medium. J Cell Physiol 115: 217–223, 1983
Bergmeyer HU, Bernt E: Methods of Enzymatic Analysis.New York, Academic, pp 579–582, 1974
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Massaeli, H., Austria, J.A. & Pierce, G.N. Overexpression of SERCA2 ATPaase in vascular smooth muscle cells treated with oxidized low density lipoprotein. Mol Cell Biochem 207, 137–141 (2000). https://doi.org/10.1023/A:1007075121729
Issue Date:
DOI: https://doi.org/10.1023/A:1007075121729